Cargando…
Introduction to pharmaceutical biotechnology. Volume 3, Animal tissue culture and biopharmaceuticals /
Introduction to Pharmaceutical Biotechnology, Volume 3: Animal tissue culture and biopharmaceuticals offers background information and knowledge on all aspects of this fascinating subject, including stem cell treatment, in vitro organ systems and cell culture technology. This book and the previous t...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Bristol [England] (Temple Circus, Temple Way, Bristol BS1 6HG, UK) :
IOP Publishing,
[2019]
|
| Colección: | IOP (Series). Release 6.
IOP expanding physics. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- 1 Introduction to animal tissue culture science 1-1
- 1.1. Introduction
- 1.2. Historical background
- 1.3. Types of cell cultures
- 1.4. Primary cell culture
- 1.5. Segregation of non-viable cells from viable cells
- 1.6. Ethical issues in animal tissue culture
- 1.7. Safety considerations in animal tissue culture
- 1.8. Cell lines (first subculture or passage)
- 1.9. Subculture
- 1.10. Suspension cultures
- 1.11. Algal extracts in animal tissue culture
- 1.12. Animal and plant tissue culture
- 1.13. Biomaterials and animal tissue culture
- 1.14. Nanotechnology and biotechnology
- 2. Organ culture
- 2.1. Organ culture
- 2.2. Histotypic culture
- 2.3. Artificial skin
- 3. Stem cell culture
- 3.1. Introduction
- 3.2. Embryonic stem cells
- 3.3. Epithelial stem cells
- 3.4. Cancer cell culture
- 3.5. Maintenance of stem cells
- 3.6. Adult stem cells
- 3.7. Applications of cultured stem cells
- 4. Culture media for animal cells
- 4.1. Introduction
- 4.2. Physical and chemical properties of culture media
- 4.3. Balanced salt solutions (BSS)
- 4.4. Growth medium
- 4.5. Serum
- 4.6. Bioreactors in animal tissue culture
- 4.7. Serum-free media
- 5. Animal tissue culture facilities
- 5.1. Introduction
- 5.2. Infrastructural requirements
- 5.3. Equipment
- 5.4. Culture vessels
- 5.5. Sterilization procedures in animal tissue cultures
- 5.6. Aseptic conditions
- 5.7. Sterilization procedures
- 5.8. Advantages and disadvantages of animal tissue culture
- 5.9. Safety regulations for animal tissue culture laboratories
- 6. Characterization of cultured cells
- 6.1. Introduction
- 6.2. Cell proliferation, differentiation and metabolism
- 6.3. Characterization of cultured cells
- 6.4. Parameters of characterization
- 6.5. Characterization of stem cells
- 6.6. Applications of animal cell cultures
- 7. Role of pharmacists in delivering biotechnological products
- 7.1. Introduction
- 7.2. The role of the pharmacist
- 7.3. The route of administration for biopharmaceuticals
- 7.4. Development of biopharmaceuticals
- 7.5. Basic requirements for biotechnology based products
- 7.6. Strategies adopted by pharmacists for dealing with biopharmaceuticals
- 7.7. Protein crystals for the delivery of biopharmaceuticals
- 7.8. Patient care, education, training and follow-up
- 7.9. Physical factor assessment (related to the serious medical history of the patient)
- 7.10. Emotional and environmental factor assessment
- 7.11. Knowledge of products and suitable delivery systems
- 7.12. Preservatives and biopharmaceuticals
- 7.13. Dosing schedules
- 7.14. Education regarding adverse effects and prevention strategies for most biopharmaceuticals
- 7.15. Treatment with adjuvant
- 7.16. Dosage errors
- 7.17. Proper supply
- 7.18. Familiarity with terminology and the biotechnological literature
- 7.19. Dealing with expensive biopharmaceuticals
- 7.20. Generic biopharmaceuticals
- 7.21. Collaboration between pharmacies, wholesalers and manufacturers
- 7.22. Reimbursement issues and biopharmaceuticals
- 7.23. Third party reimbursement issues with biopharmaceuticals
- 7.24. Affordable therapy and biopharmaceuticals
- 7.25. Information on the right reimbursement policy for biopharmaceuticals
- 7.26. Direct reimbursement of biopharmaceuticals
- 7.27. Dispensing fee reimbursement when dealing with biopharmaceuticals
- 7.28. Proper refrigeration of biopharmaceuticals
- 7.29. Stock management of biopharmaceuticals
- 7.30. Drug loss due to premature discontinuation of medications
- 7.31. The future pharmacist who can efficiently deal with biopharmaceuticals
- 7.32. Stability issues of biopharmaceuticals.